The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis

Abstract Background Pulmonary arterial hypertension (PAH) is characterized by a progressive increase in pulmonary vascular resistance and pulmonary arterial pressure, with complex etiology, difficult treatment and poor prognosis. The objective of this study was to investigate the potential biomarker...

Full description

Bibliographic Details
Main Authors: Weibin Wu, Ai Chen, Siming Lin, Qiuran Wang, Guili Lian, Li Luo, Liangdi Xie
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-022-02275-6
_version_ 1811292023841357824
author Weibin Wu
Ai Chen
Siming Lin
Qiuran Wang
Guili Lian
Li Luo
Liangdi Xie
author_facet Weibin Wu
Ai Chen
Siming Lin
Qiuran Wang
Guili Lian
Li Luo
Liangdi Xie
author_sort Weibin Wu
collection DOAJ
description Abstract Background Pulmonary arterial hypertension (PAH) is characterized by a progressive increase in pulmonary vascular resistance and pulmonary arterial pressure, with complex etiology, difficult treatment and poor prognosis. The objective of this study was to investigate the potential biomarkers for PAH based on bioinformatics analysis. Methods The GSE117261 datasets were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified by screening PAH patients and controls. Then the DEGs were analyzed using a Weighted Gene Co-expression Network Analysis (WGCNA) and the key modules were determined, and to further explore their potential biological functions via Gene Ontology analysis (GO), Kyoto Encyclopedia of Genes and Genomes Pathway analysis (KEGG), and Gene Set Enrichment Analysis (GSEA). Moreover, Protein–protein interaction (PPI) networks were constructed to identify hub gene candidates in the key modules. Finally, real-time quantitative polymerase chain reaction was supplied to detect the expressions of hub genes in human pulmonary arterial smooth cells treated with cobalt chloride (COCl2) which was used to mimic hypoxia. Results There were 2299 DEGs identified. WGCNA indicated that yellow module was the key one correlated with PAH. GO and KEGG analysis demonstrated that genes in the yellow module were mainly enriched in ‘Pathways in cancer’. GSEA revealed that ‘HALLMARK_MYC_TARGETS_V1’ was remarkably enriched in PAH. Based on the PPI network, vascular endothelial growth factor A, proto-oncogene receptor tyrosine kinase (KIT), PNN interacting serine and arginine rich protein (PNISR) and heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) were identified as the hub genes. Additionally, the PCR indicated that the elevated expressions of PNISR and HNRNPH1 were in line with the bioinformatics analysis. ROC analysis determined that PNISR and HNRNPH1 may be potential biomarkers to provide better diagnosis of PAH. Conclusion PNISR and HNRNPH1 were potential biomarkers to diagnosis PAH. In summary, the identified DEGs, modules, pathways, and hub genes provide clues and shed light on the potential molecular mechanisms of PAH.
first_indexed 2024-04-13T04:38:16Z
format Article
id doaj.art-d6a802864b4247fb9d4722f71ed4d549
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-04-13T04:38:16Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-d6a802864b4247fb9d4722f71ed4d5492022-12-22T03:02:06ZengBMCBMC Pulmonary Medicine1471-24662022-12-0122111110.1186/s12890-022-02275-6The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysisWeibin Wu0Ai Chen1Siming Lin2Qiuran Wang3Guili Lian4Li Luo5Liangdi Xie6Department of Geriatrics, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical UniversityFujian Hypertension Research Institute, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical UniversityAbstract Background Pulmonary arterial hypertension (PAH) is characterized by a progressive increase in pulmonary vascular resistance and pulmonary arterial pressure, with complex etiology, difficult treatment and poor prognosis. The objective of this study was to investigate the potential biomarkers for PAH based on bioinformatics analysis. Methods The GSE117261 datasets were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified by screening PAH patients and controls. Then the DEGs were analyzed using a Weighted Gene Co-expression Network Analysis (WGCNA) and the key modules were determined, and to further explore their potential biological functions via Gene Ontology analysis (GO), Kyoto Encyclopedia of Genes and Genomes Pathway analysis (KEGG), and Gene Set Enrichment Analysis (GSEA). Moreover, Protein–protein interaction (PPI) networks were constructed to identify hub gene candidates in the key modules. Finally, real-time quantitative polymerase chain reaction was supplied to detect the expressions of hub genes in human pulmonary arterial smooth cells treated with cobalt chloride (COCl2) which was used to mimic hypoxia. Results There were 2299 DEGs identified. WGCNA indicated that yellow module was the key one correlated with PAH. GO and KEGG analysis demonstrated that genes in the yellow module were mainly enriched in ‘Pathways in cancer’. GSEA revealed that ‘HALLMARK_MYC_TARGETS_V1’ was remarkably enriched in PAH. Based on the PPI network, vascular endothelial growth factor A, proto-oncogene receptor tyrosine kinase (KIT), PNN interacting serine and arginine rich protein (PNISR) and heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) were identified as the hub genes. Additionally, the PCR indicated that the elevated expressions of PNISR and HNRNPH1 were in line with the bioinformatics analysis. ROC analysis determined that PNISR and HNRNPH1 may be potential biomarkers to provide better diagnosis of PAH. Conclusion PNISR and HNRNPH1 were potential biomarkers to diagnosis PAH. In summary, the identified DEGs, modules, pathways, and hub genes provide clues and shed light on the potential molecular mechanisms of PAH.https://doi.org/10.1186/s12890-022-02275-6Hub genesPulmonary arterial hypertensionWGCNAGSEABioinformatics
spellingShingle Weibin Wu
Ai Chen
Siming Lin
Qiuran Wang
Guili Lian
Li Luo
Liangdi Xie
The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
BMC Pulmonary Medicine
Hub genes
Pulmonary arterial hypertension
WGCNA
GSEA
Bioinformatics
title The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
title_full The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
title_fullStr The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
title_full_unstemmed The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
title_short The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
title_sort identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co expression network analysis
topic Hub genes
Pulmonary arterial hypertension
WGCNA
GSEA
Bioinformatics
url https://doi.org/10.1186/s12890-022-02275-6
work_keys_str_mv AT weibinwu theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT aichen theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT siminglin theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT qiuranwang theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT guililian theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT liluo theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT liangdixie theidentificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT weibinwu identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT aichen identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT siminglin identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT qiuranwang identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT guililian identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT liluo identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis
AT liangdixie identificationandverificationofhubgenesassociatedwithpulmonaryarterialhypertensionusingweightedgenecoexpressionnetworkanalysis